TG-101209

• Description:

  A potent, selective, orally bioavailable JAK2 inhibitor with IC50 of 6 nM; also inhibits FLT3 (IC50=25 nM) and RET (IC50=17 nM) kinases, weakly inhibits JAK3 (IC50=168 nM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  509.6668

• Molecular Formula:

  C26H35N7O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  FLT3|JAK2|JAK3|RET

• CAS Number:

  936091-14-4